안정남 교수
전문진료분야
급. 만성 신장질환, 투석, 사구체질환, 일반신장질환
전화 예약
1577-1801
기본정보
학력
2014.03 ~ 2018.02서울대학교 대학원 박사 2011.03 ~ 2013.02서울대학교 대학원 석사 2002.03 ~ 2008.02중앙대학교 의과대학 학사 |
경력
2023.03 ~ 한림대학교성심병원 신장내과 부교수 2020.03 ~ 2023.02한림대학교성심병원 신장내과 임상조교수 2016.03 ~ 2020.03서울특별시보라매병원 진료조교수 2013.03 ~ 2016.02서울대학교병원 신장내과 임상강사 2009.03 ~ 2013.02서울대학교병원 내과 전공의 2008.03 ~ 2009.02서울대학교병원 인턴 |
학회활동
2012.03 ~ 대한이식학회 정회원 2012.03 ~ 대한내과학회 정회원 2011.04 ~ 대한신장학회 정회원 |
수상이력
2019.03보라매의학상 ‘젊은연구자상’ 2018.07보라매병원 IRB 우수위원 2016.05대한신장학회 우수연구자상 2015.05대한신장학회 우수연구자상 2015.05대한신장학회 우수초록상 |
논문
Urine myo-inositol as a novel prognostic biomarker for diabetic kidney disease: a targeted metabolomics study using nuclear magnetic resonance (Kidney Research and Clinical Practice)
Elevated Ferritin Levels Associated with High Body Fat Mass Affect Mortality in Peritoneal Dialysis Patients (NUTRIENTS)
Predicting outcomes of continuous renal replacement therapy using body composition monitoring: a deep-learning approach (SCIENTIFIC REPORTS)
Low serum total CO2 and its association with mortality in patients being followed up in the nephrology outpatients clinic (SCIENTIFIC REPORTS)
Urinary cMet as a prognostic marker in immunoglobulin A nephropathy (Journal of Cellular and Molecular Medicine)
Portal inflammation predicts renal dysfunction in patients with nonalcoholic fatty liver disease (Hepatology international)
cMet agonistic antibody attenuates apoptosis in ischaemia-reperfusion-induced kidney injury (JOURNAL OF CELLULAR AND MOLECULAR MEDICINE)
Elevated Ferritin Levels Associated with High Body Fat Mass Affect Mortality in Peritoneal Dialysis Patients (NUTRIENTS)
Predicting outcomes of continuous renal replacement therapy using body composition monitoring: a deep-learning approach (SCIENTIFIC REPORTS)
Low serum total CO2 and its association with mortality in patients being followed up in the nephrology outpatients clinic (SCIENTIFIC REPORTS)
Urinary cMet as a prognostic marker in immunoglobulin A nephropathy (Journal of Cellular and Molecular Medicine)
Portal inflammation predicts renal dysfunction in patients with nonalcoholic fatty liver disease (Hepatology international)
cMet agonistic antibody attenuates apoptosis in ischaemia-reperfusion-induced kidney injury (JOURNAL OF CELLULAR AND MOLECULAR MEDICINE)